David Aaron Schwartz

USPTO Granted Patents = 47 (Patent Applications = 17)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 20

Forward Citations = 999(Granted Patents)

Location History:

Exton, PA (US) (1988 - 2001)
Morristown, NJ (US) (2015 - 2017)
Encinitas, CA (US) (1997 - 2024)

Company Filing History:

Promega Biosciences, Inc.

patents

4. 4 out of 4

Solulink Biosciences, Inc.

patents

5. 4 out of 4

Solulink Incorporated

patents

6. 4 out of 915

University of Chicago

Smithkline Beecham Corporation

Dynavax Technologies Corporation

patents

12. 1 out of 834

Johnson Matthey Public Limited Company

Solulink Bioscience, Inc.

Dicerna Pharmaceuticals, Inc.

patents

17. 1 out of 423

Emd Millipore Corporation

19. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12291738 - Methods and/or use of oligonucleotide conjugates for assays and flow cytometry detections (2025-05-06),

2. 12168674 - Reagents and methods for the highly-efficient synthesis and purification of biopolymers (2024-12-17),

3. 12123874 - Reagent compounds, compositions, kits, and methods for amplified assays (2024-10-22),

4. 11867696 - Antigen-coupled immunoreagents (2024-01-09),

5. 9669042 - Compositions and formulations of glucosamine for transdermal and transmucosal administration (2017-06-06),

6. 9549983 - Amine cationic lipids and uses thereof (2017-01-24),

7. RE46171 - Functional biopolymer modification reagents and uses thereof (2016-10-03),

8. 9222936 - Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization (2015-12-29),

9. 9012430 - Compositions and formulations of glucosamine for transdermal and transmucosal administration (2015-04-21),

10. 8846875 - Preparation and/or purification of oligonucleotide conjugates (2014-09-30),

11. 8580516 - Methods and compositions for direct detection of DNA damage (2013-11-12),

12. 8541555 - Hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers (2013-09-24),

13. 7999098 - Triphosphate oligonucleotide modification reagents and uses thereof (2011-08-16),

14. 7732628 - Functional biopolymer modification reagents and uses thereof (2010-06-08),

15. 7462689 - Hydrazine-based and carbonyl-based bifunctional crosslinking reagents (2008-12-09),

Title: The Innovative Mind of David Aaron Schwartz

Introduction: David Aaron Schwartz, a talented inventor based in Encinitas, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Schwartz's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, Schwartz has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, Schwartz has collaborated with leading technology companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: David Aaron Schwartz's passion for innovation and dedication to pushing the boundaries of technology have solidified his reputation as a pioneering inventor in the field. His relentless pursuit of excellence continues to inspire the next generation of inventors to think outside the box and create solutions that shape the future.

This text is generated by artificial intelligence and may not be accurate.